Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis
Authors:
- 17 May 2013
- journal article
- review article
- Published by Springer Nature in Frontiers of Medicine
- Vol. 7 (2) , 157-171
Abstract
Non-small-cell lung cancer (NSCLC) is the most common cause of premature death among the malignant diseases worldwide. The current staging criteria do not fully capture the complexity of this disease. Molecular biology techniques, particularly gene expression microarrays, proteomics, and next-generation sequencing, have recently been developed to facilitate effectively its molecular classification. The underlying etiology, pathogenesis, therapeutics, and prognosis of NSCLC based on an improved molecular classification scheme may promote individualized treatment and improve clinical outcomes. This review focuses on the molecular classification of NSCLC based on gene expression microarray technology reported during the past decade, as well as their applications for improving the diagnosis, staging and treatment of NSCLC, including the discovery of prognostic markers or potential therapeutic targets. We highlight some of the recent studies that may refine the identification of NSCLC subtypes using novel techniques such as epigenetics, proteomics, or deep sequencing.Keywords
This publication has 83 references indexed in Scilit:
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancerCarcinogenesis, 2012
- Accumulation of driver and passenger mutations during tumor progressionProceedings of the National Academy of Sciences, 2010
- Systems Biology Modeling of the Radiation Sensitivity Network: A Biomarker Discovery PlatformInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Epigenetics in cancerCarcinogenesis, 2009
- MicroRNA expression profiling of human metastatic cancers identifies cancer gene targetsThe Journal of Pathology, 2009
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- Gene expression profiling of Non-small cell lung cancerLung Cancer, 2008
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002